Linda Sherman

Sherman was born in 1950 in Brooklyn, New York, to European parents who had immigrated to the United States in 1947; her father had survived Auschwitz and her mother had also been incarcerated in a labor camp during the Second World War.

She then spent 18 months as a postdoctoral fellow in the department of pathology of Harvard Medical School, under Steve Burakoff and Baruj Benacerraf, where she studied cellular immunology, becoming interested in T cells (1977–78).

[3][5] Sherman wrote in 2014 that she believed many diseases not usually considered immunological in nature would turn out to be curable by immune-based therapies.

One focus of her recent work has been the phosphatase PTPN22, a variant form of which is associated with increased risk of autoimmune disease.

[1] One of their sons has a developmental disability,[1] and Sherman and Klinman were involved in the San Diego charity, Kids Included Together, which supports such children.